Results 161 to 170 of about 8,578 (238)

Interstitial pneumonitis related to sacituzumab govitecan in a patient with metastatic triple-negative breast cancer: a case report. [PDF]

J Med Case Rep
Lin MC, Lin CW.
europepmc   +1 more source

The future of urothelial carcinoma: a 2024-2025 update of early-phase trials of novel therapeutic agents. [PDF]

Curr Opin Urol
Lee YHA, Wong CM, Liu AQ, Teoh JY.
europepmc   +1 more source

Fluorogenic Imaging Enables the Identification of Phosphoramidate Antibody-Drug Conjugate Linkers. [PDF]

Bioconjug Chem
Shrestha P, Edupuganti VVSR, Wang C, Patel NL, Thang L, Difilippantonio S, Schnermann MJ.   +6 more
europepmc   +1 more source

Mass spectrometric imaging and quantitative analysis of the <i>in vivo</i> biodistribution of trastuzumab using a rhodium(iii) sarcophagine complex.

Inorg Chem Front
Patel N, Pham TT, Banu A, Griffiths A, Paterson BM, Firth G, Morrell A, McMahon C, Long NJ, Baker JR, Chudasama V, Ma MT.   +11 more
europepmc   +1 more source

Nonglycosylated, Legumain-Cleavable ISACs Drive Potent Antitumor Immunotherapy via a Bystander Effect. [PDF]

Mol Cancer Ther
Zhang A, Mullapudi MR, Wu L, Yi M, Rahman MA, Yaseen AA, Zhong HK, Brooks TA, Tumey LN.   +8 more
europepmc   +1 more source

Polatuzumab vedotin plus rituximab with chemotherapy in newly diagnosed pediatric stage IV Burkitt lymphoma: case report highlighting early complete remission. [PDF]

Front Immunol
Sun Y, Deng M, Zhang C, Chen Y, Zhang Y, Zuo W.   +5 more
europepmc   +1 more source

Health economic evaluation of Mirvetuximab soravtansine for the treatment of FRα-positive, platinum resistant ovarian cancer in Germany. [PDF]

J Cancer Res Clin Oncol
Janke FF, Baldessarini RJ, Bauerschlag D, Zibolka S, Hartmann M.   +4 more
europepmc   +1 more source

Case report: Spatiotemporal HER2 heterogeneity in AFP-producing gastric cancer: navigating long-term survival with molecularly-guided therapy in a refractory case. [PDF]

Front Immunol
Diao Y, Yin H, Sun X, Dong Q, Zhang J.
europepmc   +1 more source

EGFR-targeting RNase A-cetuximab antibody-drug conjugate induces ROS-mediated apoptosis to overcome drug resistance in KRAS mutant cancer cells. [PDF]

Sci Rep
Jafary B, Akbarzadeh-Khiavi M, Farzi-Khajeh H, Safary A, Adibkia K.   +4 more
europepmc   +1 more source

A Kinetically Controlled Bioconjugation Method for the Synthesis of Radioimmunoconjugates and the Development of a Domain Mapping MS-Workflow for Its Characterization. [PDF]

Bioconjug Chem
Pometti MA, Di Natale G, Geremia G, Gauswami N, Garufi G, Ricciardi G, Sciortino M, Scopelliti F, Russo G, Ippolito M.   +9 more
europepmc   +1 more source